Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9069)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2023 (publication date) through Mar 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Al Bitar S, El-Sabban M, Doughan S, Abou-Kheir W. Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond. World J Gastroenterol 2023; 29(9): 1395-1426 [PMID: 36998426 DOI: 10.3748/wjg.v29.i9.1395] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i9/1395.htm |
| Number | Citing Articles |
| 1 |
Xiang-Yuan Tao, Qian-Qian Li, Yong Zeng. Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02063-2
|
| 2 |
Anggraeni E. Kusumaningrum, Sarce Makaba, Eyhab Ali, Mandeep Singh, Mohammed N. Fenjan, Irodakhon Rasulova, Neeti Misra, Sada G. Al‐ Musawi, Ali Alsalamy. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance. Cell Biochemistry and Function 2024; 42(1) doi: 10.1002/cbf.3906
|
| 3 |
Xiangyu Meng, Xiao Bai, Angting Ke, Kaiqiang Li, Yun Lei, Siqi Ding, Dongqiu Dai. Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications. Biomolecules 2024; 14(6): 608 doi: 10.3390/biom14060608
|
| 4 |
Sikhumbuzo Z. Mbatha, Rupert C. Ecker, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 323 doi: 10.1016/B978-0-443-33475-7.00005-6
|
| 5 |
Ki-Hyun Kim, Young-Lan Park, Sun-Young Park, Young-Eun Joo. Expression of an oxysterol-metabolizing enzyme in colorectal cancer and its relation to tumor cell behavior and prognosis. Pathology - Research and Practice 2023; 251: 154875 doi: 10.1016/j.prp.2023.154875
|
| 6 |
Wen-Yu Luan, Hao Lin, Yan-Dong Miao. Recommendations for articles and reviews in colorectal cancer-related research at the year-end of 2023. World Journal of Gastroenterology 2024; 30(30): 3548-3553 doi: 10.3748/wjg.v30.i30.3548
|
| 7 |
Mingtang Zeng, Yao Wang, Xuelin Tao, Tianfei Fan, Xi Yin, Chao Shen, Xueyan Wang. Novel Perspectives in the Management of Colorectal Cancer: Mechanistic Investigations Into the Reversal of Drug Resistance via Active Constituents Derived From Herbal Medicine. Phytotherapy Research 2024; 38(12): 5962 doi: 10.1002/ptr.8363
|
| 8 |
Sathan Raj Natarajan, Rajapandiyan Krishnamoorthy, Mohammad A. Alshuniaber, Khalid Mashay Al-Anazi, Mohammad Abul Farah, Ponnulakshmi Rajagopal, Chella Perumal Palanisamy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman. Identification of FOXM1 as a novel protein biomarker and therapeutic target for colorectal cancer progression: Evidence from immune infiltration and bioinformatic analyses. International Journal of Biological Macromolecules 2024; 282: 137201 doi: 10.1016/j.ijbiomac.2024.137201
|
| 9 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09431-7
|
| 10 |
Amir Torshizi Esfahani, Somayeh Mohammadpour, Pooya Jalali, Alireza Yaghoobi, Raana Karimpour, Soha Torkamani, Ali Pardakhtchi, Zahra Salehi, Ehsan Nazemalhosseini-Mojarad. Differential expression of angiogenesis-related genes ‘VEGF’ and ‘angiopoietin-1’ in metastatic and EMAST-positive colorectal cancer patients. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-61000-x
|
| 11 |
Harikumar Pallathadka, Chou-Yi Hsu, Raed Obaid Saleh, S. Renuka Jyothi, Ashwani Kumar, Alexey Yumashev, Aashna Sinha, Ahmed Hussein Zwamel, Mohammed Abed Jawad, Salim B. Alsaadi. Specific small interfering RNAs (siRNAs) for targeting the metastasis, immune responses, and drug resistance of colorectal cancer cells (CRC). International Immunopharmacology 2024; 140: 112730 doi: 10.1016/j.intimp.2024.112730
|
| 12 |
Lloyd Mabonga, Rebecca Leony Fourie, Abidemi Paul Kappo, Sylvester Lyantagaye, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 107 doi: 10.1016/B978-0-443-33475-7.00001-9
|
| 13 |
Elham Farrokhnazar, Sahar Moghbelinejad, Reza Najafipour, Ladan Teimoori-Toolabi. MiR-3664-3p through suppressing ABCG2, CYP3A4, MCL1, and MLH1 increases the sensitivity of colorectal cancer cells to irinotecan. Heliyon 2025; 11(3): e41933 doi: 10.1016/j.heliyon.2025.e41933
|
| 14 |
Mohd Farhan. Insights on the Role of Polyphenols in Combating Cancer Drug Resistance. Biomedicines 2023; 11(6): 1709 doi: 10.3390/biomedicines11061709
|
| 15 |
Yoonsuk Lee, Yun Young Lee, Jinyoung Park, Anna Maksakova, Donghyuk Seo, Jisun Kim, Ji Eun Yeom, Yewon Kim, Cheol-Hwi Kim, Rhim Ryoo, Se-Na Kim, Juwon Park, Wooram Park, Tae-Hyung Kim, Young Bin Choy, Chun Gwon Park, Ki Hyun Kim, Wonhwa Lee. Illudin S inhibits p53-Mdm2 interaction for anticancer efficacy in colorectal cancer. Biomedicine & Pharmacotherapy 2025; 182: 117795 doi: 10.1016/j.biopha.2024.117795
|
| 16 |
Lizhe Huang, Cun Liao, Zuming Xiong, Zhongyang Chen, Sen Zhang. Hsa-miR-526b-5p Regulates the Sensitivity of Colorectal Cancer to 5-Fluorouracil by Targeting TP53 in Organoid Models. Biochemical Genetics 2025; doi: 10.1007/s10528-025-11045-y
|
| 17 |
Sara Cherri, Ester Oneda, Laura Zanotti, Alberto Zaniboni. Optimizing the first-line treatment for metastatic colorectal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1246716
|
| 18 |
Hu Chenghao, Liu Xuefeng, Pang Junli, Wang Ke, Li Haixia, Hu Guangyue, Luo Qingqin, Wu Feng. Mitochondrial-targeting strategies with homoharringtonine: A novel approach for chemoresistant rectal cancer. Biochemical and Biophysical Research Communications 2025; 743: 151141 doi: 10.1016/j.bbrc.2024.151141
|
| 19 |
Beatriz Leme Boaro, Enzo Pereira de Lima, Durvanei Augusto Maria, Rose Eli Grassi Rici, Adriano Cressoni Araújo, Elen Landgraf Guiguer, Eliana de Souza Bastos Mazuqueli Pereira, Caroline Barbalho Lamas, Claudia Rucco Penteado Detregiachi, Adriana Maria Ragassi Fiorini, Antonely de Cássio Alves de Carvalho, Lucas Fornari Laurindo, Sandra Maria Barbalho. Cinobufagin: Unveiling the hidden bufadienolide’s promise in combating alimentary canal cancer development and progression – a comprehensive review. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; doi: 10.1007/s00210-025-03902-9
|
| 20 |
Ming Jiang, Wenjuan Li, Jinzhe Liang, Min Pang, Shanhe Li, Gang Xu, Minghui Zhu, Hong Liang, Zhenlei Zhang, Feng Yang. Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response. Journal of Medicinal Chemistry 2024; 67(18): 16296 doi: 10.1021/acs.jmedchem.4c01175
|
| 21 |
Shuoxi Guo, Meiqi Chen, Shuangyang Li, Zijun Geng, Ye Jin, Da Liu. Natural Products Treat Colorectal Cancer by Regulating miRNA. Pharmaceuticals 2023; 16(8): 1122 doi: 10.3390/ph16081122
|
| 22 |
Elise Pretzsch, Christiane A. Peschel, Matjaz Rokavec, Lucien Torlot, Pan Li, Heiko Hermeking, Jens Werner, Frederick Klauschen, Jens Neumann, Andreas Jung, Jörg Kumbrink. Five-Gene Expression Signature Associated With Acquired FOLFIRI Resistance and Survival in Metastatic Colorectal Cancer. Laboratory Investigation 2025; 105(5): 104107 doi: 10.1016/j.labinv.2025.104107
|
| 23 |
Jun Wang, Lijuan Zhu, Yuanyuan Li, Mingming Ding, Xiyu Wang, Bo Xiong, Hongyu Chen, Lisheng Chang, Wenli Chen, Bo Han, Jun Lu, Qin Shi. Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulation. Frontiers in Genetics 2025; 16 doi: 10.3389/fgene.2025.1560172
|
| 24 |
Anjing Zhao, Xingchao Zhu, Hongya Wu, Jiayu Wang, Mengting Zhang, Jingrong Xiang, Suhua Xia, Tongguo Shi, Qinhua Xi. B7-H3 promotes the migration and invasion of colorectal cancer cells via regulating the actin cytoskeleton and RhoA/ROCK1/LIMK1 signaling pathway. Tissue and Cell 2024; 90: 102518 doi: 10.1016/j.tice.2024.102518
|
| 25 |
Jiasheng Li, Shanshan Ma, Qiuhua Lin, Qin Wang, Wuning Zhong, Chunyin Wei, Junjie Liu, Jie Chen, Duo Wang, Weizhong Tang, Tao Luo. Orchestrated copper-loaded nanoreactor for simultaneous induction of cuproptosis and immunotherapeutic intervention in colorectal cancer. Materials Today Bio 2024; 29: 101326 doi: 10.1016/j.mtbio.2024.101326
|
| 26 |
Julia Pospieszna, Hanna Dams-Kozlowska, Wachirawit Udomsak, Marek Murias, Malgorzata Kucinska. Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets. International Journal of Molecular Sciences 2023; 24(13): 10910 doi: 10.3390/ijms241310910
|
| 27 |
Wei Wang, Jing Wang, Xiu-Xiu Ren, Hai-Long Yue, Zheng Li. Effects of invigorating-spleen and anticancer prescription on extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway in colon cancer mice model. World Journal of Gastrointestinal Oncology 2024; 16(11): 4468-4476 doi: 10.4251/wjgo.v16.i11.4468
|
| 28 |
Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia. WEE1 Inhibition by AZD1775 Augments Colorectal Cancer Cells
Susceptibility to VE-822-induced DNA Damage and Apoptosis. Drug Research 2025; 75(02): 66 doi: 10.1055/a-2499-3067
|
| 29 |
Wanmei Lin, Lijun Xu, Yaoying Li, Junze Li, Liang Zhao. Aberrant FAM135B attenuates the efficacy of chemotherapy in colorectal cancer by modulating SRSF1-mediated alternative splicing. Oncogene 2024; 43(48): 3532 doi: 10.1038/s41388-024-03189-9
|
| 30 |
Yan-Xu Hou, Wei Ren, Qing-Qiang He, Li-Yan Huang, Tian-Hua Gao, Hua Li. Tetramethylpyrazine induces reactive oxygen species-based mitochondria-mediated apoptosis in colon cancer cells. World Journal of Gastrointestinal Oncology 2025; 17(4): 104922 doi: 10.4251/wjgo.v17.i4.104922
|
| 31 |
Dennis C. George, Fred E. Bertrand, George Sigounas. Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes. Advances in Biological Regulation 2024; 91: 101013 doi: 10.1016/j.jbior.2024.101013
|
| 32 |
Juan Zhang, Zhihan Li, Jiaxu Han, Zhongtao Tian, Qingyu Meng, Wenbo Niu. KLF7 enhances the invasion and migration of colorectal cancer cells via the miR-139-5p/TPD52 axis. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2385172
|